雜志介紹

Journal Of Breast Cancer雜志介紹

《Journal Of Breast Cancer》是一本以English/Korean為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱乳腺癌雜志，本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.2，最新CiteScore 指數(shù)為3.8。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Pokemon Inhibits Transforming Growth Factor β-Smad4-Related Cell Proliferation Arrest in Breast Cancer through Specificity Protein 1.

  Author: Chen L¹, Zhong J¹, Liu JH¹, Liao DF², Shen YY¹, Zhong XL¹, Xiao X¹, Ding WJ¹, Peng XD¹, Xiong W³, Zu XY¹.

• Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death.

  Author: Fu J¹, Zhong C^2,3, Wu L^4,5, Li D^2,3, Xu T⁶, Jiang T⁷, Yang J⁸, Du J⁹.

• Whole Exome Sequencing in the Accurate Diagnosis of Bilateral Breast Cancer: a Case Study.

  Author: Li X^1,2, Yang M², Zhang Q³, Fan Y³, Zhu T², Chen F², Wang K^1,2.

• Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide.

  Author: Ro J, Cheng FT, Sriuranpong V, Villalon A, Smruti BK, Tsang J, Yap YS; Asian Working Group for Eribulin Clinical Guide.

英文介紹

Journal Of Breast Cancer雜志英文介紹

The Journal of Breast Cancer (abbreviated as 'J Breast Cancer') is the official journal of the Korean Breast Cancer Society, which is issued quarterly in the last day of March, June, September, and December each year since 1998. All the contents of the Journal is available online at the official journal website (http://ejbc.kr) under open access policy. The journal aims to provide a forum for the academic communication between medical doctors, basic science researchers, and health care professionals to be interested in breast cancer. To get this aim, we publish original investigations, review articles, brief communications including case reports, editorial opinions on the topics of importance to breast cancer, and welcome new research findings and epidemiological studies, especially when they contain a regional data to grab the international reader's interest. Although the journal is mainly dealing with the issues of breast cancer, rare cases among benign breast diseases or evidence-based scientifically written articles providing useful information for clinical practice can be published as well.